BRAINLIFE.ORG





Neuro-Oncology Reviews




Volume 25 Number 19
15 October 2023




Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 19, 15 October






Gottardo NG.
"Coming Full Circle": Reintroduction of Radiotherapy Delaying Chemotherapy Followed by Craniospinal Radiotherapy for Infants With Medulloblastoma.
J Natl Compr Canc Netw. 2023 Oct;21(10):988-990. doi: 10.6004/jnccn.2023.7090. PMID: 37856224. Comment.
ˍ
Refers to:
Bagchi A, et al.,
Molecular Classification Improves Therapeutic Options for Infants and Young Children With Medulloblastoma.
J Natl Compr Canc Netw. 2023 Aug 28:1-9. doi: 10.6004/jnccn.2023.7024. PMID: 37643637. Review. ˍ



*

Gu P, Ding Y, Zheng G, Xu P, Xia X.
Extracranial metastasis of glioblastoma: A case report and literature review.
Int J Surg Case Rep. 2023 Oct 1;111:108895. doi: 10.1016/j.ijscr.2023.108895. PMID: 37812956.
Case report, Review. ˍ



*

Shcherbina V, Kovalevska L, Pedachenko E, Malysheva T, Kashuba E.
Comparative Analysis of the Embryonal Brain Tumors Based on Their Molecular Features.
Discov Med. 2023 Oct 1;35(178):733-749. doi: 10.24976/Discov.Med.202335178.69. PMID: 37811612. Review.
ˍ



*

Galev G, Weigelt MA, Prayson RA.
Tumor-to-tumor metastasis of an adenocarcinoma to a glioblastoma with review of the literature on tumor-to-tumor metastasis to gliomas.
Clin Neuropathol. 2023 Oct 2
. doi: 10.5414/NP301578. PMID: 37779445. Case report, Review˰ ˍ




Nichelli L, Zaiss M, Casagranda S.
APT weighted imaging in diffuse gliomas.
BJR Open. 2023 Oct 3;5(1):20230025. doi: 10.1259/bjro.20230025. PMID: 37942492. Review.
ˍ




Ziemann C, Cremers F, Motisi L, Albers D, MacPherson M, Rades D.
Novel hybrid treatment planning approach for irradiation a pediatric craniospinal axis.
Med Dosim. 2023 Oct 3:S0958-3947(23)00076-6
. doi: 10.1016/j.meddos.2023.08.011. PMID: 37798155. Review. ˍ




Anderson JB, Bouchal SM, Zhang L, Daniels DJ.
STAT3 as a biologically relevant target in H3K27M-mutant diffuse midline glioma.
Oncotarget. 2023 Oct 4;14:858-859
. doi: 10.18632/oncotarget.28516. PMID: 37791912. Editorial perspective. ˍ



*

Lost J, Verma T, Jekel L, von Reppert M, Tillmanns N, Merkaj S, Petersen GC, Bahar R, Gordem A, Haider MA, Subramanian H, Brim W, Ikuta I, Omuro A, Conte GM, Marquez-Nostra BV, Avesta A, Bousabarah K, Nabavizadeh A, Kazerooni AF, Aneja S, Bakas S, Lin M, Sabel M, Aboian M.
Systematic Literature Review of Machine Learning Algorithms Using Pretherapy Radiologic Imaging for Glioma Molecular Subtype Prediction.
AJNR Am J Neuroradiol. 2023 Oct 4;44(10):1126-1134
. doi: 10.3174/ajnr.A8000. PMID: 37770204. Review. ˍ




Pratt D, Penas-Prado M, Gilbert MR.
Clinical impact of molecular profiling in rare brain tumors.
Curr Opin Neurol. 2023 Oct 4;36(6):579-586. doi: 10.1097/WCO.0000000000001211. PMID: 37973025. Review˰
ˍ




Nelson TA, Dietrich J.
Investigational treatment strategies in glioblastoma: progress made and barriers to success.
Expert Opin Investig Drugs. 2023 Oct 5
. doi: 10.1080/13543784.2023.2267982. PMID: 37796104. Review˰ ˍ




Robinson SD, Samuels M, Jones W, Gilbert D, Critchley G, Giamas G.
Shooting the messenger: a systematic review investigating extracellular vesicle isolation and characterisation methods and their influence on understanding extracellular vesicles-radiotherapy interactions in glioblastoma.
BMC Cancer. 2023 Oct 5;23(1):939
. doi: 10.1186/s12885-023-11437-6. PMID: 37798728. Review. ˍ



*

Zhang HY, Yu HY, Zhao GX, Jiang XZ, Gao G, Wei BJ.
Global research trends in immunotherapy for glioma: a comprehensive visualization and bibliometric analysis.
Front Endocrinol (Lausanne). 2023 Oct 5;14:1273634. doi: 10.3389/fendo.2023.1273634. PMID: 37867521. Bibliometric analysis.
ˍ



*

Al Sharie S, Abu Laban D, Al-Hussaini M.
Decoding Diffuse Midline Gliomas: A Comprehensive Review of Pathogenesis, Diagnosis and Treatment.
Cancers (Basel). 2023 Oct 6;15(19):4869. doi: 10.3390/cancers15194869. PMID: 37835563. Review.
ˍ



*

Kim H, Lee K, Phi JH, Paek SH, Yun H, Choi SH, Park SH.
Neuroepithelial tumor with EWSR1::PATZ1 fusion: A literature review.
J Neuropathol Exp Neurol. 2023 Oct 6:nlad076
. doi: 10.1093/jnen/nlad076. PMID: 37804108. Case report˰ ˍ




Kwiatkowska-Miernik A, Mruk B, Sklinda K, Zaczyński A, Walecki J.
Radiomics in the diagnosis of glioblastoma.
Pol J Radiol. 2023 Oct 6;88:e461-e466. doi: 10.5114/pjr.2023.132168. PMID: 38020501. Review.
ˍ




Bin-Alamer O, Abou-Al-Shaar H, Gersey ZC, Huq S, Kallos JA, McCarthy DJ, Head JR, Andrews E, Zhang X, Hadjipanayis CG.
Intraoperative Imaging and Optical Visualization Techniques for Brain Tumor Resection: A Narrative Review.
Cancers (Basel). 2023 Oct 9;15(19):4890. doi: 10.3390/cancers15194890. PMID: 37835584. Review.
ˍ




Felistia Y, Wen PY.
Molecular Profiling and Targeted Therapies in Gliomas.
Curr Neurol Neurosci Rep. 2023 Oct 9. doi: 10.1007/s11910-023-01299-7. PMID: 37812369. Review˰
ˍ




Inoue A, Ohnishi T, Nishikawa M, Ohtsuka Y, Kusakabe K, Yano H, Tanaka J, Kunieda T.
A Narrative Review on CD44's Role in Glioblastoma Invasion, Proliferation, and Tumor Recurrence.
Cancers (Basel). 2023 Oct 9;15(19):4898. doi: 10.3390/cancers15194898. PMID: 37835592. Review.
ˍ



*

Kurdi M, Baeesa S, Okal F, Bamaga AK, Faizo E, Fathaddin AA, Alkhotani A, Karami MM, Bahakeem B.
Extracranial metastasis of brain glioblastoma outside CNS: Pathogenesis revisited.
Cancer Rep (Hoboken). 2023 Oct 9:e1905. doi: 10.1002/cnr2.1905. PMID: 37814403. Review.
ˍ




Ohmura K, Tomita H, Hara A.
Peritumoral Edema in Gliomas: A Review of Mechanisms and Management.
Biomedicines. 2023 Oct 9;11(10):2731. doi: 10.3390/biomedicines11102731. PMID: 37893105. Review.
ˍ




Agosti E, Zeppieri M, De Maria L, Tedeschi C, Fontanella MM, Panciani PP, Ius T.
Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.
Int J Mol Sci. 2023 Oct 10;24(20):15037. doi: 10.3390/ijms242015037. PMID: 37894718. Review.
ˍ




Agrawal K, Asthana S, Kumar D.
Role of Oxidative Stress in Metabolic Reprogramming of Brain Cancer.
Cancers (Basel). 2023 Oct 10;15(20):4920. doi: 10.3390/cancers15204920. PMID: 37894287. Review.
ˍ




Cockle JV, Corley EA, Zebian B, Hettige S, Vaidya SJ, Angelini P, Stone J, Leitch RJ, Albanese A, Mandeville HC, Carceller F, Marshall LV.
Novel therapeutic approaches for pediatric diencephalic tumors: improving functional outcomes.
Front Oncol. 2023 Oct 10;13:1178553. doi: 10.3389/fonc.2023.1178553. PMID: 37886179. Review.
ˍ




Quintero JC, Díaz NF, Rodríguez-Dorantes M, Camacho-Arroyo I.
Cancer Stem Cells and Androgen Receptor Signaling: Partners in Disease Progression.
Int J Mol Sci. 2023 Oct 11;24(20):15085. doi: 10.3390/ijms242015085. PMID: 37894767. Review.
ˍ




Rumler S.
Non-cellular immunotherapies in pediatric central nervous system tumors.
Front Immunol. 2023 Oct 11;14:1242911. doi: 10.3389/fimmu.2023.1242911. PMID: 37885882. Review. ˍ




Saratsis AM, Knowles T, Petrovic A, Nazarian J.
H3K27M Mutant Glioma: Disease Definition and Biological Underpinnings.
Neuro Oncol. 2023 Oct 11:noad164. doi: 10.1093/neuonc/noad164. PMID: 37818718. Review.
ˍ




Sharma S, Chepurna O, Sun T.
Drug resistance in glioblastoma: from chemo- to immunotherapy.
Cancer Drug Resist. 2023 Oct 11;6(4):688-708. doi: 10.20517/cdr.2023.82. PMID: 38239396. Review. ˍ




Bonosi L, Torrente A, Brighina F, Tito Petralia CC, Merlino P, Avallone C, Gulino V, Costanzo R, Brunasso L, Iacopino DG, Maugeri R.
"Cortico-Cortical Evoked Potentials in Eloquent Brain Tumor Surgery. A Systematic Review".
World Neurosurg. 2023 Oct 12:S1878-8750(23)01433-X. doi: 10.1016/j.wneu.2023.10.028. PMID: 37832637. Review.
ˍ




Marei HE, Wang L, Cenciarelli C, Zhang W, Hua W.
Editorial: Research progress on immune microenvironment and molecular mechanism of glioma.
Front Oncol. 2023 Oct 12;13:1288309. doi: 10.3389/fonc.2023.1288309. PMID: 37901320. Editorial.
ˍ




Sánchez J, Martín-Landrove M.
Multifractal Analysis of Brain Tumor Interface in Glioblastoma.
Adv Neurobiol. 2023 Oct 12;36:487-499. doi: 10.1007/978-3-031-47606-8_25. PMID: 38468049. Review˰ ˍ




Tejada Solís S, Iglesias Lozano I, Meana Carballo L, Mollejo Villanueva M, Díez Valle R, González Sánchez J, Fernández Coello A, Al Ghanem R, García Duque S, Olivares Granados G, Plans Ahicart G, Hostalot Panisello C, Garcia Romero JC, Narros Giménez JL; Grupo de trabajo de la SENEC.
Brain metastasis treatment guidelines: consensus by the Spanish Society of Neurosurgery Tumor Section.
Neurocirugia (Astur: Engl Ed). 2023 Oct 12:S2529-8496(23)00041-2. doi: 10.1016/j.neucie.2023.07.010. PMID: 37832786. Guidelines˰
ˍ




Comba A, Li X, Breznik B.
Editorial: Brain cancer pathogenesis and data integration.
Front Genet. 2023 Oct 13;14:1298285. doi: 10.3389/fgene.2023.1298285. PMID: 37900188. Editorial.
ˍ




Karita H, Tsurubuchi T, Amano T, Koiso T, Sakamoto N, Ishikawa E.
Spinal cord diffuse midline glioma with postoperative acute swelling: A case report and review of literature.
Surg Neurol Int. 2023 Oct 13;14:360. doi: 10.25259/SNI_636_2023. PMID: 37941612. Case report, Review.
ˍ




Jaraíz-Rodríguez M, Del Prado L, Balsa E.
Metabolic remodeling in astrocytes: Paving the path to brain tumor development.
Neurobiol Dis. 2023 Oct 13;188:106327. doi: 10.1016/j.nbd.2023.106327. PMID: 37839712. Review.
ˍ




Jayaram MA, Phillips JJ.
Role of the Microenvironment in Glioma Pathogenesis.
Annu Rev Pathol. 2023 Oct 13. doi: 10.1146/annurev-pathmechdis-051122-110348. PMID: 37832944. Review˰
ˍ




Liu S, Wang W, Hu S, Jia B, Tuo B, Sun H, Wang Q, Liu Y, Sun Z.
Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity.
Cell Death Dis. 2023 Oct 13;14(10):679. doi: 10.1038/s41419-023-06211-2. PMID: 37833255. Review.
ˍ




Messiaen J, Jacobs SA, De Smet F.
The tumor micro-environment in pediatric glioma: friend or foe?
Front Immunol. 2023 Oct 13;14:1227126. doi: 10.3389/fimmu.2023.1227126. PMID: 37901250. Review.
ˍ




Ruiz Esparza Garrido R, Velázquez Flores MÁ.
Circular RNAs: the next level of gene regulation.
Am J Transl Res. 2023 Oct 15;15(10):6122-6135. PMID: 37969203. Review.
ˍ